GenomeWeb

Australian Firm Genetic Signatures Raises $25M; Eyes US, European Markets

Nov 27, 2019

|

NEW YORK – Australian molecular diagnostics firm Genetic Signatures has raised $25 million, it said on Wednesday.

The investors in the financing were Regal Funds Management, Perennial Value Management, Asia Union Investments, and Karst Peak Capital, a spokesman for Genetic Signatures said. Asia Union Investments is the family office of Genetic Signaures majority holder and Cofounder Chris Abbott.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Nobel Representation

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Bill to Address Foreign Influence

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research.

Promising, But More Needed

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.